These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9886434)

  • 1. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
    Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
    J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein.
    Vieyres G; Dubuisson J; Patel AH
    J Gen Virol; 2011 Mar; 92(Pt 3):494-506. PubMed ID: 21084495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.
    Li C; Candotti D; Allain JP
    J Virol; 2001 Dec; 75(24):12412-20. PubMed ID: 11711631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
    Cusick MF; Yang M; Gill JC; Eckels DD
    Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus antigenic convergence.
    Campo DS; Dimitrova Z; Yokosawa J; Hoang D; Perez NO; Ramachandran S; Khudyakov Y
    Sci Rep; 2012; 2():267. PubMed ID: 22355779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus.
    Xiu BS; Ling SG; Song XG; Zhang HQ; Chen K; Zhu CX
    World J Gastroenterol; 2003 Jun; 9(6):1256-60. PubMed ID: 12800235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused antibody response to influenza linked to antigenic drift.
    Huang KY; Rijal P; Schimanski L; Powell TJ; Lin TY; McCauley JW; Daniels RS; Townsend AR
    J Clin Invest; 2015 Jul; 125(7):2631-45. PubMed ID: 26011643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected maintenance of hepatitis C viral diversity following liver transplantation.
    Gray RR; Strickland SL; Veras NM; Goodenow MM; Pybus OG; Lemon SM; Fried MW; Nelson DR; Salemi M
    J Virol; 2012 Aug; 86(16):8432-9. PubMed ID: 22623804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.
    Thomson EC; Smith JA; Klenerman P
    J Gen Virol; 2011 Oct; 92(Pt 10):2227-2236. PubMed ID: 21775583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positional effect of phosphorylation sites 266 and 267 in the cytoplasmic domain of the E2 protein of hepatitis C virus 3a genotype: interferon resistance analysis via sequence alignment.
    Rafique S; Idrees M; Ilyas M; Hussain A; Ali M; Ali L; Butt S; Afzal S; Ur Rehman I; Saleem S
    Virol J; 2011 May; 8():204. PubMed ID: 21545731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of rare peptide segments in the HCV immunome.
    Stufano A; Capone G; Pesetti B; Polimeno L; Kanduc D
    Self Nonself; 2010 Apr; 1(2):154-162. PubMed ID: 21487517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).
    Laskus T; Wilkinson J; Karim R; Mack W; Radkowski M; deGiacomo M; Nasseri J; Chen Z; Xu J; Kovacs A
    Hepatology; 2007 Aug; 46(2):359-70. PubMed ID: 17659581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstruction of a pathway of antigen processing and class II MHC peptide capture.
    Moss CX; Tree TI; Watts C
    EMBO J; 2007 Apr; 26(8):2137-47. PubMed ID: 17396153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens.
    Gupta V; Tabiin TM; Sun K; Chandrasekaran A; Anwar A; Yang K; Chikhlikar P; Salmon J; Brusic V; Marques ET; Kellathur SN; August TJ
    Virology; 2006 Mar; 347(1):127-39. PubMed ID: 16387339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.
    Castelletti D; Fracasso G; Righetti S; Tridente G; Schnell R; Engert A; Colombatti M
    Clin Exp Immunol; 2004 May; 136(2):365-72. PubMed ID: 15086403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression.
    Sheridan I; Pybus OG; Holmes EC; Klenerman P
    J Virol; 2004 Apr; 78(7):3447-54. PubMed ID: 15016867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
    Gregorio GV; Choudhuri K; Ma Y; Pensati P; Iorio R; Grant P; Garson J; Bogdanos DP; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 2003 Sep; 133(3):404-13. PubMed ID: 12930368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses.
    Mondelli MU; Cerino A; Meola A; Nicosia A
    J Biosci; 2003 Apr; 28(3):305-10. PubMed ID: 12734408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.
    Surman S; Lockey TD; Slobod KS; Jones B; Riberdy JM; White SW; Doherty PC; Hurwitz JL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4587-92. PubMed ID: 11287644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.